Fidelity Investments’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-161
| Closed | -$11K | – | 4507 |
|
|
2019
Q3 | $11K | Sell |
161
-395,616
| -100% | -$27.2M | ﹤0.01% | 3223 |
|
|
2019
Q2 | $23M | Sell |
395,777
-134,860
| -25% | -$7.99M | ﹤0.01% | 1565 |
|
|
2019
Q1 | $37.2M | Sell |
530,637
-19,990
| -4% | -$1.48M | ﹤0.01% | 1344 |
|
|
2018
Q4 | $35.5M | Buy |
550,627
+251,085
| +84% | +$17.6M | ﹤0.01% | 1315 |
|
|
2018
Q3 | $21M | Buy |
299,542
+166,681
| +125% | +$9.75M | ﹤0.01% | 1662 |
|
|
2018
Q2 | $6.7M | Sell |
132,861
-30
| -0% | -$1.19K | ﹤0.01% | 2064 |
|
|
2018
Q1 | $4.16M | Sell |
132,891
-38,063
| -22% | -$1.26M | ﹤0.01% | 2220 |
|
|
2017
Q4 | $5.85M | Sell |
170,954
-59,028
| -26% | -$1.88M | ﹤0.01% | 2121 |
|
|
2017
Q3 | $7.38M | Sell |
229,982
-23,966
| -9% | -$756K | ﹤0.01% | 2043 |
|
|
2017
Q2 | $8.27M | Buy |
253,948
+7,600
| +3% | +$241K | ﹤0.01% | 2011 |
|
|
2017
Q1 | $7.76M | Sell |
246,348
-17,000
| -6% | -$503K | ﹤0.01% | 2050 |
|
|
2016
Q4 | $7.74M | Sell |
263,348
-74,900
| -22% | -$2.28M | ﹤0.01% | 2053 |
|
|
2016
Q3 | $9.78M | Sell |
338,248
-186,900
| -36% | -$5.21M | ﹤0.01% | 1990 |
|
|
2016
Q2 | $13.6M | Hold |
525,148
| – | – | ﹤0.01% | 1836 |
|
|
2016
Q1 | $13M | Sell |
525,148
-45,200
| -8% | -$1.24M | ﹤0.01% | 1847 |
|
|
2015
Q4 | $20.1M | Hold |
570,348
| – | – | ﹤0.01% | 1691 |
|
|
2015
Q3 | $12.1M | Sell |
570,348
-31,732
| -5% | -$818K | ﹤0.01% | 1874 |
|
|
2015
Q2 | $16.7M | Buy |
602,080
+21,732
| +4% | +$613K | ﹤0.01% | 1806 |
|
|
2015
Q1 | $17.7M | Sell |
580,348
-492,503
| -46% | -$15.7M | ﹤0.01% | 1767 |
|
|
2014
Q4 | $34.3M | Sell |
1,072,851
-332,797
| -24% | -$10.8M | ﹤0.01% | 1504 |
|
|
2014
Q3 | $39.8M | Sell |
1,405,648
-533,640
| -28% | -$14.9M | 0.01% | 1408 |
|
|
2014
Q2 | $53.1M | Sell |
1,939,288
-878,421
| -31% | -$23.4M | 0.01% | 1316 |
|
|
2014
Q1 | $74.2M | Buy |
2,817,709
+743,607
| +36% | +$21.3M | 0.01% | 1137 |
|
|
2013
Q4 | $60.7M | Sell |
2,074,102
-10,873
| -0.5% | -$345K | 0.01% | 1216 |
|
|
2013
Q3 | $63.8M | Sell |
2,084,975
-29,744
| -1% | -$995K | 0.01% | 1169 |
|
|
2013
Q2 | $67.1M | Buy |
+2,114,719
| New | +$69.5M | 0.01% | 1105 |
|
Fidelity Investments's GHDX Position: Q4 2019 in Review
Fidelity Investments sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 161 shares — an estimated $11K sold.
Fidelity Investments first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $74.2M in Q1 2014. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Fidelity Investments reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Fidelity Investments sold 161 Genomic Health, Inc. shares in Q4 2019, an estimated $11K.
- Fidelity Investments first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Fidelity Investments's Genomic Health, Inc. position peaked at $74.2M in Q1 2014.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Fidelity Investments's 13F filing for Q4 2019, filed 7 Feb 2020.